Advanced Search
Your search returned 34 results
  • Aug 24, 2021
    Strong Financial Performance on Continued Procedure Volume Recovery and Share Gains from New Product Launches

    Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2022, which ended July 30, 2021. Key Highlights Revenue of $8.0 Billion Increased 23% Reported and...

  • Aug 6, 2021
    Acquisition to Add Innovative Bioabsorbable Drug Release Platform to Chronic Rhinosinusitis Portfolio

    Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has entered into a definitive agreement with Intersect ENT (NASDAQ: XENT), a global ear, nose, and throat...

  • Sep 12, 2017
    New Platform to Offer Enhanced Visualization and Increased Efficiency for Surgery of the Sinuses and Skull Base

    DUBLIN - September 12, 2017 - Medtronic plc (NYSE: MDT) today announced the global launch of the StealthStation(TM) ENT, a new surgical navigation system designed for surgeons treating conditions...

  • Dec 16, 2014
    Medtronic Philanthropy Grants Support Local Organizations Committed to Expanding Access to Healthcare for the Underserved

    MINNEAPOLIS - December 16, 2014 - Rocky Mountain Youth Clinics, Roundup River Ranch and the Parkinson Association of the Rockies each received a two-year $50,000 Health Access Grant from Medtronic...

  • Dec 15, 2014
    NovaShield(TM) Offers Convenient Tool to Control Minimal Bleeding, Prevent Adhesions, and Provide Antibacterial Effectiveness after FESS*

    MINNEAPOLIS - December 15, 2014 - Medtronic (NYSE: MDT) today announced the launch of the NovaShield(TM) Injectable Nasal Packing and Stent for functional endoscopic sinus surgery (FESS),...

Show 5102550100 per page